Recent general press releases & news

Looking for the latest news on the products and services you patronize? Presswire is your go-to website. Presswire is the leading online news and press release distribution service. Used by thousands of organizations of every size to get better visibility, improve their ranks on the search engines, drive traffic to their website, and deliver the latest news to their respective target audiences. Presswire's press release distribution services go to various media outlets in our media contacts database, keeping everyone in-the-know informed. Do you have a news story to feature? Send and create your stories or product and service news to Presswire, but filling out the form here.


QUERIDO PAPÁ NOEL: La Oficina de Correos Central de Papá Noel en Finlandia revela cuáles son los regalos más deseados por los niños en 2022


[PRESSWIRE] LAPONIA, FINLANDIA - DICIEMBRE DE 2022: La Oficina de Correos Central de Papá Noel en Rovaniemi, Finlandia, junto con Posti, el servicio postal finés, ha analizado centenares de cartas dirigidas a Papá Noel de niños y adultos de todo el mundo. Los datos de las cartas a Papá Noel revelan que los principales deseos de Navidad son la familia, la salud y la felicidad, en lugar de dispositivos electrónicos y juguetes.


New digital tablet study service, KUMON CONNECT is launched by Kumon Europe & Africa


[PRESSWIRE] London, UK - 07.12.22 -- Kumon Europe & Africa (President, Mr Masahiro Shimizu) will begin offering KUMON CONNECT, a Kumon Method of Learning service using digital tablets, at Kumon study centres from January 2023.


Analysis of Sanctions for Russia - the Effect on Europe


[PRESSWIRE] The Netherlands - 02.12.22 -- Arnaud Develay, an international lawyer and expert at the Center for Geopolitical Studies, analyzed the current economic situation in Europe after the implementation of sanctions for Russia.


Europe is at a crossroads for crop protection innovation


[PRESSWIRE] Brussels - 1 December, 2022 -- As part of our 2030 commitments, CropLife Europe reports an investment of nearly €4 billion in biopesticides and digital & precision ag technologies. Investment outpaces the European regulatory framework’s ability to approve them.


Theresa Gavigan and John Gomez Join the Western National Park Association Board of Directors


[PRESSWIRE] Tucson, AZ - 29.11.22 -- Two people, one a leader in business and volunteerism and the other an avid hiker and business executive, have joined the Western National Parks Association (WNPA) board of directors.


Big Ben: An Icon of Democracy and Leadership


[PRESSWIRE] London, UK - 25.11.22 -- Published by St James’s House, this new book celebrates one of Britain’s most famous and enduring cultural icons, Big Ben, charting its history and recent restoration, as well as the history of the wider Palace of Westminster, and exploring its status as a symbol of democracy and leadership around the world.


eBay Delivery Requests Up By 20% As Consumers Turn To Second-Hand Items In The Cost Of Living Crisis


[PRESSWIRE] London, UK - 28th October 2022 -- Requests for delivery of eBay ‘collection only’ items have jumped by 20% in the first half of 2022 when compared to 2020, displaying the strong effect that the cost of living crisis is having on consumer behaviour.

Bronco Wine Company’s Board of Directors select a new President/CEO


[PRESSWIRE] Ceres, CA - September 22, 2022 -- The Board of Directors is pleased to announce Daniel J. Leonard as Bronco Wine Company’s new President/CEO...


SyncMo’s Real-Time Video Sync Technology Takes Sex Toys to the Next Level


[PRESSWIRE] London, UK - September 13, 2022 -- SyncMo’s revolutionary technology enables sex toy users to feel the movement in ANY live or recorded video as they watch it. They’ll enjoy the action on their screens, feel the pleasure, fun and sexual wellness benefits simultaneously.  



ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results


[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – August 15, 2022 – ProMIS Neurosciences, Inc. (TSX: PMN) (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, today announced its operational and financial results for the three months ended June 30, 2022.